Search

everythinglearnresearchcommunity

for

Search:↓

Patients need better information about the risks of long-term steroid use.

Oral minoxidil helps hair regrowth in 80% of alopecia patients, but only 18% see cosmetic improvement.

Alopecia areata patients have lower zinc, copper, and selenium levels than healthy people.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

Zinc deficiency in alcoholic cirrhosis patients causes skin issues, and zinc treatment improves symptoms.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

Dupilumab for skin problems might reactivate hair loss in some patients.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

Minoxidil can cause deadly skin reaction; monitor patients closely.

Dermatologists should respect Muslim patients' cultural and religious practices for better care.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Negative expectations can cause adverse effects in patients even without active treatment, and managing this nocebo effect involves better communication and patient-clinician relationships.

Low-dose isotretinoin combined with pulsed azithromycin cleared acne in most patients, with mild side effects.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Pharmacists play a key role in helping patients use over-the-counter products correctly, including those for hair regrowth and smoking cessation.

Baricitinib significantly regrows hair in severe alopecia areata patients.

The model and estimator can predict drug exposure in kidney transplant patients well.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

Proteins from stem cells improved hair growth in patients with hair loss.